Artwork

Konten disediakan oleh Tom Aarts. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Tom Aarts atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Player FM - Aplikasi Podcast
Offline dengan aplikasi Player FM !

NBT # 25 Sarah Kennedy and Dr. Ed Walker: Ozempic & Natural Alternatives that Work

45:37
 
Bagikan
 

Manage episode 410685336 series 3566825
Konten disediakan oleh Tom Aarts. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Tom Aarts atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.

On this latest episode of Nutrition Business Today, host Tom Aarts and his guests pick apart this surge of weight loss supplements, that followed the recent 'Ozempic craze'.
Coming all the way from New Zealand, six-time CEO Sarah Kennedy and scientist lecturer at the University of Aukland, Dr. Ed Walker cut through the noise on natural products in this category and what claims have the science to back them up
Ozempic, just one of the pharmaceutical semaglutide injectables developed for diabetes, has stormed the media with its effectiveness when it comes to weight loss and management. But is there cause for concern? Are some users unable to withstand the side effects, or perhaps they are not comfortable with injections? Regardless, consumers are looking for natural alternatives and Calocurb's patented delivery of the main ingredient, Amerasate, is the only natural GLP-1 agonist on the market. With a $20 million research investment from the NZ government, Calocurb has the science to solidify these claims. Join us as we discuss what it takes from a business and science perspective to enter this volatile category.
Find Calocurb at https://www.calocurb.com/
For interested practitioners, visit https://wholesale.calocurb.com/

  continue reading

27 episode

Artwork
iconBagikan
 
Manage episode 410685336 series 3566825
Konten disediakan oleh Tom Aarts. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Tom Aarts atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.

On this latest episode of Nutrition Business Today, host Tom Aarts and his guests pick apart this surge of weight loss supplements, that followed the recent 'Ozempic craze'.
Coming all the way from New Zealand, six-time CEO Sarah Kennedy and scientist lecturer at the University of Aukland, Dr. Ed Walker cut through the noise on natural products in this category and what claims have the science to back them up
Ozempic, just one of the pharmaceutical semaglutide injectables developed for diabetes, has stormed the media with its effectiveness when it comes to weight loss and management. But is there cause for concern? Are some users unable to withstand the side effects, or perhaps they are not comfortable with injections? Regardless, consumers are looking for natural alternatives and Calocurb's patented delivery of the main ingredient, Amerasate, is the only natural GLP-1 agonist on the market. With a $20 million research investment from the NZ government, Calocurb has the science to solidify these claims. Join us as we discuss what it takes from a business and science perspective to enter this volatile category.
Find Calocurb at https://www.calocurb.com/
For interested practitioners, visit https://wholesale.calocurb.com/

  continue reading

27 episode

Tous les épisodes

×
 
Loading …

Selamat datang di Player FM!

Player FM memindai web untuk mencari podcast berkualitas tinggi untuk Anda nikmati saat ini. Ini adalah aplikasi podcast terbaik dan bekerja untuk Android, iPhone, dan web. Daftar untuk menyinkronkan langganan di seluruh perangkat.

 

Panduan Referensi Cepat